Who
Kentaro Suzuki
Chief Marketing Officer
Company insider
Files Form 4 as: Chief Marketing Officer, Nautilus Biotechnology.
In numbers
- Trades disclosed
- 5
- Buys
- 1
- Sells
- 0
- Bought
- $5,960
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Sep 2024
- Last trade
- 2 Mar 2026
- Last filed
- 4 Mar 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Mar 2026filed 4 Mar 2026 | NAUT Nautilus Biotechnologyoption or derivative · Life-science tools | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | NAUT Nautilus Biotechnologyoption or derivative · Life-science tools | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 6 Nov 2025filed 10 Nov 2025 | NAUT Nautilus BiotechnologyLife-science tools | SEC FORM 4 Bought | $5,9604,000 at $1.49 | filing |
| 3 Mar 2025filed 4 Mar 2025 | NAUT Nautilus Biotechnologyoption or derivative · Life-science tools | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 16 Sep 2024filed 17 Sep 2024 | NAUT Nautilus Biotechnologyoption or derivative · Life-science tools | SEC FORM 4 Code A | —375,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.